Atlas Venture Associates IX’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$316K	Hold	10,000	–	–	2.69%	6
2023 Q2	$408K	Hold	10,000	–	–	2.23%	6
2023 Q1	$373K	Hold	10,000	–	–	1.75%	6
2022 Q4	$349K	Hold	10,000	–	–	1.74%	6
2022 Q3	$560K	Hold	10,000	–	–	1.66%	6
2022 Q2	$518K	Hold	10,000	–	–	1.18%	7
2022 Q1	$727K	Hold	10,000	–	–	0.67%	7
2021 Q4	$1.18M	Hold	10,000	–	–	0.52%	7
2021 Q3	$1.34M	Hold	10,000	–	–	0.45%	7
2021 Q2	$1.62M	Sell	10,000 -1,103,376	-99%	-$179M	0.28%	7
2021 Q1	$89.4M	Sell	1,113,376 -501,945	-31%	-$40.3M	15.01%	2
2020 Q4	$87.9M	Hold	1,615,321	–	–	13.93%	2
2020 Q3	$32.1M	Hold	1,615,321	–	–	33.22%	1
2020 Q2	$34M	Hold	1,615,321	–	–	36.31%	1
2020 Q1	$19.8M	Hold	1,615,321	–	–	41.77%	1
2019 Q4	$23.7M	Hold	1,615,321	–	–	41.29%	1
2019 Q3	$21.6M	Hold	1,615,321	–	–	35.49%	1
2019 Q2	$26.4M	Hold	1,615,321	–	–	28.28%	1
2019 Q1	$27.6M	Hold	1,615,321	–	–	25.92%	1
2018 Q4	$22M	Hold	1,615,321	–	–	25.39%	1
2018 Q3	$46.2M	Sell	1,615,321 -221,489	-12%	-$6.34M	24.47%	2
2018 Q2	$50.3M	Sell	1,836,810 -442,978	-19%	-$12.1M	22.12%	2
2018 Q1	$48.1M	Sell	2,279,788 -1,300,000	-36%	-$27.4M	36.34%	1
2017 Q4	$68.8M	Hold	3,579,788	–	–	60.94%	1
2017 Q3	$89M	Sell	3,579,788 -150,000	-4%	-$3.73M	62.83%	1
2017 Q2	$59.7M	Hold	3,729,788	–	–	95.72%	1
2017 Q1	$52.6M	Sell	3,729,788 -700,000	-16%	-$9.86M	100%	1
2016 Q4	$58.1M	Buy	+4,429,788	New	+$58.1M	100%	1